While there has not been a study to systematically investigate the direct effect of SH3BP4 in the context of melanoma progression, a recent report identified SH3BP4 as a novel pigmentation gene that is inversely regulated by a validated melanoma prognostic marker miR-125b (55–58). The gene discussed is SH3BP4; the disease is melanoma.